Ferroptosis-Related Flavoproteins: Their Function and Stability
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Effective Ferroptotic Small-Cell Lung Cancer Cell Death from SLC7A11 Inhibition by Sulforaphane
ONCOLOGY LETTERS 21: 71, 2021 Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane YUKO IIDA1*, MAYUMI OKAMOTO-KATSUYAMA1*, SHUICHIRO MARUOKA1, KENJI MIZUMURA1, TETSUO SHIMIZU1, SOTARO SHIKANO1, MARI HIKICHI1, MAI TAKAHASHI1, KOTA TSUYA1, SHINICHI OKAMOTO1, TOSHIO INOUE1, YOKO NAKANISHI2, NORIAKI TAKAHASHI1, SHINOBU MASUDA2, SHU HASHIMOTO1,3 and YASUHIRO GON1 1Division of Respiratory Medicine, Department of Internal Medicine; 2Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 173-8610; 3Shonan University of Medical Science, Kanagawa 244-0806, Japan Received October 20, 2019; Accepted October 14, 2020 DOI: 10.3892/ol.2020.12332 Abstract. Small-cell lung cancer (SCLC) is a highly aggres- lower in SFN-treated cells compared with that in the control sive cancer with poor prognosis, due to a lack of therapeutic cells (P<0.0001 and P=0.0006, respectively). These results targets. Sulforaphane (SFN) is an isothiocyanate derived indicated that the anticancer effects of SFN may be caused from cruciferous vegetables and has shown anticancer effects by ferroptosis in the SCLC cells, which was hypothesized against numerous types of cancer. However, its anticancer to be triggered from the inhibition of mRNA and protein effect against SCLC remains unclear. The present study aimed expression levels of SLC7A11. In conclusion, the present study to demonstrate the anticancer effects of SFN in SCLC cells by demonstrated that SFN-induced cell death was mediated via investigating cell death (ferroptosis, necroptosis and caspase ferroptosis and inhibition of the mRNA and protein expression inhibition). The human SCLC cell lines NCI-H69, NCI-H69AR levels of SLC7A11 in SCLC cells. -
Glutathione Reductase (Ec 1.6.4.2)
Enzymatic Assay of GLUTATHIONE REDUCTASE (EC 1.6.4.2) PRINCIPLE: ß-NADPH + GSSG Glutathione Reductase> ß-NADP + 2 GSH Abbreviations used: ß-NADPH = ß-Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form ß-NADP = ß-Nicotinamide Adenine Dinucleotide Phosphate, Oxidized Form GSSG = Glutathione, Oxidized Form GSH = Glutathione, Reduced Form CONDITIONS: T = 25°C, pH = 7.6, A340nm, Light Path = 1 cm METHOD: Continuous Spectrophotometric Rate Determination REAGENTS: A. 100 mM Potassium Phosphate Buffer with 3.4 mM Ethylenediaminetetraacetic Acid (EDTA), pH 7.6 at 25°C (Prepare 200 ml in deionized water using Potassium Phosphate, Monobasic, Anhydrous, Sigma Prod. No. P-5379 and Ethylenediaminetetraacetic Acid, Dipotassium Salt, Sigma Stock No. ED2P. Adjust to pH 7.6 at 25°C with 1 M KOH.) B. 30 mM Glutathione Substrate Solution (GSSG) (Prepare 5 ml in deionized water using Glutathione, Oxidized Form, Disodium Salt, Sigma Prod. No. G-4626.) C. 0.8 mM ß-Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form Solution (ß-NADPH) (Prepare 5 ml in cold Reagent A using ß-Nicotinamide Adenine Dinucleotide Phosphate, Tetrasodium Salt, Sigma Prod. No. N-1630.) D. 1.0% (w/v) Bovine Serum Albumin (BSA) (Prepare 100 ml in Reagent A using Albumin, Bovine, Sigma Prod. No. A-4503. This solution should be kept cold.) SPGLUT01 Page 1 of 3 Revised: 08/03/95 Enzymatic Assay of GLUTATHIONE REDUCTASE (EC 1.6.4.2) REAGENTS: (continued) E. Glutathione Reductase Enzyme Solution (Immediately before use, prepare a solution containing 0.30 - 0.60 unit/ml of Glutathione Reductase in cold Reagent D.) PROCEDURE: Pipette (in milliliters) the following reagents into suitable cuvettes: Test Blank Deionized Water 0.65 0.65 Reagent A (Buffer) 1.50 1.50 Reagent B (GSSG) 0.10 0.10 Reagent C (ß-NADPH) 0.35 0.35 Reagent D (BSA) 0.30 0.40 Mix by inversion and equilibrate to 25°C. -
Glutathione Reductase Human, Recombinant Expressed in Escherichia Coli
Glutathione Reductase human, recombinant expressed in Escherichia coli Catalog Number G9297 Storage Temperature –20 °C CAS RN 9001-48-3 Precautions and Disclaimer EC 1.8.1.7 (formerly 1.6.4.2) This product is for R&D use only, not for drug, Synonyms: GR, NADPH:oxidized glutathione household, or other uses. Please consult the Material oxidoreductase, glutathione-disulfide reductase Safety Data Sheet for information regarding hazards and safe handling practices. Product Description Glutathione reductase (GR) is an ubiquitous Storage/Stability flavoenzyme involved in protecting cells from stress. The product ships on wet ice and storage at –20 °C is GR catalyzes the reduction of oxidized glutathione recommended. The product is stable at –20 °C for at (GSSG) to glutathione (GSH). It is an essential least 2 years. component of the glutathione redox cycle, which maintains adequate levels of reduced cellular GSH. References GSH serves as an antioxidant, reacting with free 1. Lopez-Mirabal, H.R., and Winther, J.R., Redox radicals and organic peroxides. Glutathione is also an characteristics of the eukaryotic cytosol. Biochim. electron donor for glutathione peroxidases and a Biophys. Acta, 1783, 629-640 (2008). substrate for glutathione S-transferases contributing to 2. Qiao, M., et al., Increased expression of glutathione the detoxification and elimination of toxic electrophilic reductase in macrophages decreases 1,2 metabolites and xenobiotics. artherosclerotic lesion formation on low-density lipoproetin receptor-deficient mice. Arterioscler. Glutathione reductase is a homodimeric enzyme Thromb. Vasc. Biol., 27, 1375-1382 (2007). containing 1 FAD molecule and 1 NADPH binding 3. Worthington, D.J., and Rosemeyer, M.A., 3 domain per subunit. -
Table S4. List of Enzymes Directly Involved in the Anti-Oxidant Defense Response
Table S4. List of Enzymes directly involved in the anti-oxidant defense response. Gene Name Gene Symbol Classification/Pathway 6-phosphogluconate dehydrogenase 6PGD NADPH regeneration/Pentose Phosphate Glucose-6-phosphate dehydrogenase G6PD NADPH regeneration/Pentose Phosphate Isocitrate Dehydrogenase 1 IDH1 NADPH regeneration/Krebs Isocitrate Dehydrogenase 2 IDH2 NADPH regeneration/Krebs Malic Enzyme 1 ME1 NADPH regeneration/Krebs Methylenetetrahydrofolate dehydrogenase 1 MTHFD1 NADPH regeneration/Folate Methylenetetrahydrofolate dehydrogenase 2 MTHFD2 NADPH regeneration/Folate Nicotinamide Nucleotide Transhydrogenase NNT NADPH regeneration/NAD Catalase CAT Antioxidants/Catalses/free radical detoxification Glutamate-cysteine ligase catalytic subunit GCLC Antioxidants/Glutathione synthesis Glutamate-cysteine ligase modifier subunit GCLM Antioxidants/Glutathione synthesis Glutathione peroxidase1 GPx1 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione peroxidase2 GPx2 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione peroxidase3 GPx3 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione peroxidase4 GPx4 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione peroxidase5 GPx5 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione peroxidase6 GPx6 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione peroxidase7 GPx7 Antioxidants/Glutathione Peroxidases/free radical detoxification Glutathione S-transferase -
Progressive Encephalopathy and Central Hypoventilation Related to Homozygosity of NDUFV1 Nuclear Gene, a Rare Mitochondrial Disease
Avens Publishing Group Inviting Innovations Open Access Case Report J Pediatr Child Care August 2019 Volume:5, Issue:1 © All rights are reserved by AL-Buali MJ, et al. AvensJournal Publishing of Group Inviting Innovations Progressive Encephalopathy Pediatrics & and Central Hypoventilation Child Care AL-Buali MJ*, Al Ramadhan S, Al Buali H, Al-Faraj J and Related to Homozygosity of Al Mohanna M Pediatric Department , Maternity Children Hospital , Saudi Arabia *Address for Correspondence: NDUFV1 Nuclear Gene, a Rare Al-buali MJ, Pediatric Consultant and Consultant of Medical Genetics, Deputy Chairman of Medical Genetic Unite, Pediatrics Department , Maternity Children Hospital, Al-hassa, Hofuf city, Mitochondrial Disease Saudi Arabia; E-mail: [email protected] Submission: 15 July 2019 Accepted: 5 August 2019 Keywords: Progressive encephalopathy; Central hypoventilation; Published: 9 August 2019 Nuclear mitochondrial disease; NDUFV1 gene Copyright: © 2019 AL-Buali MJ, et al. This is an open access article distributed under the Creative Commons Attribution License, which Abstract permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background: Mitochondrial diseases are a group of disorders caused by dysfunctional organelles that generate energy for our body. Mitochondria small double-membrane organelles found in of the most common groups of genetic diseases with a minimum every cell of the human body except red blood cells. Mitochondrial diseases are sometimes caused by mutations in the mitochondrial DNA prevalence of greater than 1 in 5000 in adults. Mitochondrial diseases that affect mitochondrial function. Other mitochondrial diseases are can be present at birth but can be manifested also at any age [2]. -
Assessment of Fatty Acid Desaturase (Fads2) Structure-Function Properties in Fish in the Context of Environmental Adaptations and As a Target for Genetic Engineering
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 28 January 2020 doi:10.20944/preprints202001.0330.v1 Peer-reviewed version available at Biomolecules 2020, 10, 206; doi:10.3390/biom10020206 Review Assessment of Fatty Acid Desaturase (Fads2) Structure-Function Properties in Fish in the Context of Environmental adaptations and as a Target for Genetic Engineering Zuzana Bláhová 1*, Thomas Nelson Harvey 2, Martin Pšenička 1, Jan Mráz 1 1 University of South Bohemia in České Budějovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Zátiší 728/II, 389 25 Vodňany, Czech Republic 2 Centre for Integrative Genetics, Department of Animal and Aquacultural Sciences, Faculty of Biosciences, Norwegian University of Life Sciences, Å s, Norway * Correspondence: [email protected] Abstract: Fatty acid desaturase 2 (Fads2) is the key enzyme of long chain polyunsaturated fatty acid (LC-PUFA) biosynthesis. Endogenous production of these biomolecules in vertebrates, if present, is insufficient to meet demand. Hence, LC-PUFA are considered as conditionally-essential. At present however, LC-PUFA are globally-limited nutrients due to anthropogenic factors. Attention of research is given therefore to find ways to maximize endogenous LC-PUFA production especially in production species, whereby deeper knowledge on molecular mechanisms of enzymatic steps involved is being generated. This review first briefly informs about the milestones in the history of LC-PUFA essentiality exploration before it focuses on the main aim – to highlight the fascinating Fads2 potential to play roles fundamental to adaptation to novel environmental conditions. Investigations are summarized, which elucidate the evolutionary history of fish Fads2 providing an explanation for the remarkable plasticity of this enzyme in fish. -
In Vitro Treatment of Hepg2 Cells with Saturated Fatty Acids Reproduces
© 2015. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2015) 8, 183-191 doi:10.1242/dmm.018234 RESEARCH ARTICLE In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis Inmaculada García-Ruiz1,*, Pablo Solís-Muñoz2, Daniel Fernández-Moreira3, Teresa Muñoz-Yagüe1 and José A. Solís-Herruzo1 ABSTRACT INTRODUCTION Activity of the oxidative phosphorylation system (OXPHOS) is Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of decreased in humans and mice with nonalcoholic steatohepatitis. liver diseases extending from pure fatty liver through nonalcoholic Nitro-oxidative stress seems to be involved in its pathogenesis. The steatohepatitis (NASH) to cirrhosis and hepatocarcinoma that occurs aim of this study was to determine whether fatty acids are implicated in individuals who do not consume a significant amount of alcohol in the pathogenesis of this mitochondrial defect. In HepG2 cells, we (Matteoni et al., 1999). Although the pathogenesis of NAFLD analyzed the effect of saturated (palmitic and stearic acids) and remains undefined, the so-called ‘two hits’ model of pathogenesis monounsaturated (oleic acid) fatty acids on: OXPHOS activity; levels has been proposed (Day and James, 1998). Whereas the ‘first hit’ of protein expression of OXPHOS complexes and their subunits; gene involves the accumulation of fat in the liver, the ‘second hit’ expression and half-life of OXPHOS complexes; nitro-oxidative stress; includes oxidative stress resulting in inflammation, stellate cell and NADPH oxidase gene expression and activity. We also studied the activation, fibrogenesis and progression of NAFLD to NASH effects of inhibiting or silencing NADPH oxidase on the palmitic-acid- (Chitturi and Farrell, 2001). -
AIFM2 Monoclonal Antibody (M13A), Clone 2C6
AIFM2 monoclonal antibody (M13A), clone 2C6 Catalog # : H00084883-M13A 規格 : [ 200 uL ] List All Specification Application Image Product Mouse monoclonal antibody raised against a partial recombinant Western Blot (Transfected lysate) Description: AIFM2. Immunogen: AIFM2 (AAH06121, 1 a.a. ~ 339 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence: MGSQVSVESGALHVVIVGGGFGGIAAASQLQALNVPFMLVDMKDSFHHN VAALRASVETGFAKKTFISYSVTFKDNFRQGLVVGIDLKNQMVLLQGGE ALPFSHLILATGSTGPFPGKFNEVSSQQAAIQAYEDMVRQVQRSRFIVVV enlarge GGGSAGVEMAAEIKTEYPEKEVTLIHSQVALADKELLPSVRQEVKEILLRK Western Blot (Recombinant GVQLLLSERVSNLEELPLNEYREYIKVQTDKGTEVATNLVILCTGIKINSSA protein) YRKAFESRLASSGALRVNEHLQVEGHSNVYAIGDCADVRTPKMAYLAGL HANIAVANIVNSVKQRPLQAYKPGALTFLLSMGRNDGVG ELISA Host: Mouse Reactivity: Human Isotype: IgG1 Kappa Quality Control Antibody Reactive Against Recombinant Protein. Testing: Western Blot detection against Immunogen (62.92 KDa) . Storage Buffer: In ascites fluid Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Instruction: MSDS: Download Interspecies Mouse (90); Rat (90) Antigen Sequence: Datasheet: Download Applications Western Blot (Transfected lysate) Page 1 of 3 2021/6/18 Western Blot analysis of AIFM2 expression in transfected 293T cell line by AMID monoclonal antibody (M13A), clone 2C6. Lane 1: AIFM2 transfected lysate(40.5 KDa). Lane 2: Non-transfected lysate. Protocol Download Western Blot (Recombinant protein) Protocol Download ELISA Gene Information Entrez GeneID: 84883 GeneBank BC006121 Accession#: Protein AAH06121 Accession#: Gene Name: AIFM2 Gene Alias: AMID,PRG3,RP11-367H5.2 Gene apoptosis-inducing factor, mitochondrion-associated, 2 Description: Omim ID: 605159 Gene Ontology: Hyperlink Gene Summary: The protein encoded by this gene has significant homology to NADH oxidoreductases and the apoptosis-inducing factor PDCD8/AIF. Overexpression of this gene has been shown to induce apoptosis. The expression of this gene is found to be induced by tumor suppressor protein p53 in colon caner cells. -
Inhibitory Effects of Some Flavonoids on Thioredoxin Reductase Purified from Chicken Liver ABSTRACT INTRODUCTION
Brazilian Journal of Poultry Science Revista Brasileira de Ciência Avícola Inhibitory Effects of Some Flavonoids on ISSN 1516-635X 2019 / v.21 / n.2 / 001-008 Thioredoxin Reductase Purified from Chicken http://dx.doi.org/10.1590/1806-9061-2018-0982 Liver Original Article Author(s) ABSTRACT Türkoğlu E.AI https://orcid.org/0000-0001-7850-6456 Thioredoxin reductases (TrxRs) are selenocysteine-containing Kuzu MII https://orcid.org/0000-0002-1375-7673 flavoenzymes that reduce Trxin NADPH-dependent manner. In the Ayasan TIII https://orcid.org/0000-0001-7397-6483 view of the direct vital role of TrxR in a wide range of biochemical and IV Inci H https://orcid.org/0000-0002-9791-0435 physiological processes, methods to inhibit this enzyme are clinically Eratak SVV https://orcid.org/0000-0003-3788-8704 important. TrxR has recently emerged as a new candidate in anticancer I Department of Pharmaceutical Biotechnology, drug investigations because of overexpression in tumorous cells. In this Faculty of Pharmacy, University of Health Sciences, Istanbul 34668, Turkey. study, TrxR from chick liver was purified 94.6-fold with a yield of 4.86% II Deparment of Chemistry, Faculty of Science and a specific activity of 0.19 EU/mg. K and V values of TrxR for and Letters, Ağrı İbrahim Çeçen University, Ağrı M max 04100, Turkey. DTNB were calculated as 0.9 mM and 0,03 EU/mL, respectively. Then, III East Mediterranean Agricultural Research Institute, Karatas Road, Adana 01321, Turkey. the effects of the flavonoids hesperidin, naringenin, chlorogenic acid, IV Department of Animal Science, Faculty of ferulic acid, naringin, 3,4-dihydoxybenzoic acid, and ellagic acid on the Agriculture, Bingöl University, Bingöl 12000, Turkey. -
Structural Bases of the Altered Catalytic Properties of a Pathogenic Variant of Apoptosis Inducing Factor
Structural bases of the altered catalytic properties of a pathogenic variant of apoptosis inducing factor Luca Sorrentinoa, b , Federica Cossua, b , Mario Milania, b, Alessandro Alivertib *, Eloise Mastrangeloa, b ** aBiophysics Institute, National Research Council c/o Department of Biosciences, Università degli Studi di Milano, Via Celoria 26, 20133 Milano, Italy; bDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milano, Italy. LS and FC contributed equally to this work. * To whom correspondence should be addressed: Phone: +39 0250314897. Fax: +39 0250314895. E-mail: [email protected] ** To whom correspondence should be addressed: Phone: +39 0250314898. Fax: +39 0250314895. E-mail: [email protected] 1 Abbreviations AIFCT, AIF forms in CT complex with NAD+; AIFOX, AIF forms harboring oxidized FAD; CHCHD4, coiled-coil-helix-coiled-coil-helix domain-containing protein 4; CT, charge transfer; DCIP, 2,6-dichlorophenolindophenol; FADH-, anionic dihydroquinone form of FAD; OXPHOS, oxidative phosphorylation. 2 Abstract The apoptosis-inducing factor (AIF) is a FAD-containing protein playing critical roles in caspase-independent apoptosis and mitochondrial respiratory chain biogenesis and maintenance. While its lethal role is well known, the details of its mitochondrial function remain elusive. So far, nineteen allelic variants of AIF have been associated to human diseases, mainly affecting the nervous system. A strict correlation is emerging between the degree of impairment of its ability to stabilize the charge- transfer (CT) complex between FAD and NAD+ and the severity of the resulting pathology. Recently, we demonstrated that the G307E replacement in murine AIF (equivalent to the pathogenic G308E in the human protein) dramatically decreases the rate of CT complex formation through the destabilization of the flavoprotein interaction with NAD(H). -
UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The
UNIVERSITY OF CALIFORNIA RIVERSIDE Investigations into the Role of TAF1-mediated Phosphorylation in Gene Regulation A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Cell, Molecular and Developmental Biology by Brian James Gadd December 2012 Dissertation Committee: Dr. Xuan Liu, Chairperson Dr. Frank Sauer Dr. Frances M. Sladek Copyright by Brian James Gadd 2012 The Dissertation of Brian James Gadd is approved Committee Chairperson University of California, Riverside Acknowledgments I am thankful to Dr. Liu for her patience and support over the last eight years. I am deeply indebted to my committee members, Dr. Frank Sauer and Dr. Frances Sladek for the insightful comments on my research and this dissertation. Thanks goes out to CMDB, especially Dr. Bachant, Dr. Springer and Kathy Redd for their support. Thanks to all the members of the Liu lab both past and present. A very special thanks to the members of the Sauer lab, including Silvia, Stephane, David, Matt, Stephen, Ninuo, Toby, Josh, Alice, Alex and Flora. You have made all the years here fly by and made them so enjoyable. From the Sladek lab I want to thank Eugene, John, Linh and Karthi. Special thanks go out to all the friends I’ve made over the years here. Chris, Amber, Stephane and David, thank you so much for feeding me, encouraging me and keeping me sane. Thanks to the brothers for all your encouragement and prayers. To any I haven’t mentioned by name, I promise I haven’t forgotten all you’ve done for me during my graduate years. -
2. the Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
Molecular Mechanisms of TAZ-regulating Ferroptosis in Cancer Cells and tRNA Fragment in Erythrocytes by Wen-Hsuan Yang Department of Biochemistry Duke University Date:_______________________ Approved: ___________________________ Jen-Tsan Ashley Chi, Supervisor ___________________________ Kate Meyer ___________________________ Margarethe Kuehn ___________________________ Perry Blackshear Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2019 ABSTRACT Molecular Mechanisms of TAZ-regulating Ferroptosis in Cancer Cells and tRNA Fragment in Erythrocytes by Wen-Hsuan Yang Department of Biochemistry Duke University Date:_______________________ Approved: ___________________________ Jen-Tsan Ashley Chi, Supervisor ___________________________ Kate Meyer ___________________________ Margarethe Kuehn ___________________________ Perry Blackshear An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2019 Copyright by Wen-Hsuan Yang 2019 Abstract Here, I sought to determine the molecular mechanisms of the cellular response to stresses in two contexts. In the first part of my thesis, I focus on how ferroptosis, a lipid oxidative stress-induced cell death, can be regulated by cell density via an evolutionarily conserved pathway effector. In the second part, I focus on the transcriptional